Stopping aspirin therapy may raise heart attack, stroke risk

(Reuters Health) - Stopping low-dose aspirin therapy without good reason raises the likelihood of heart attack or stroke by nearly 40 percent, a large Swedish study suggests.

Zogenix stock soars on epilepsy drug trial success

(Reuters) - Zogenix Inc's experimental treatment for a rare form of epilepsy met the main goal in a late-stage study, the company said on Friday, more than doubling the value of its shares and hurting those of peer GW Pharmaceuticals .

U.S. FDA approves Novo Nordisk fast-acting insulin Fiasp

(Reuters) - The U.S. Food and Drug Administration on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.